|
GLP-1 Clinical Trials
3 actively recruiting trials across 2 locations
Also known as: GLP-1 Agonist, Glucagon-like peptide-1
Other1 trial
Chicago, Illinois1 trial
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
Northwestern Memorial Hospital
Philadelphia, Pennsylvania1 trial
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
Children's Hospital of Philadelphia and University of Pennsylvania
N/A
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.